KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Accumulated Expenses (2016 - 2025)

Edwards Lifesciences has reported Accumulated Expenses over the past 17 years, most recently at $1.6 billion for Q4 2025.

  • Quarterly results put Accumulated Expenses at $1.6 billion for Q4 2025, up 21.78% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (up 21.78% YoY), and the annual figure for FY2025 was $1.6 billion, up 21.78%.
  • Accumulated Expenses for Q4 2025 was $1.6 billion at Edwards Lifesciences, up from $1.4 billion in the prior quarter.
  • Over the last five years, Accumulated Expenses for EW hit a ceiling of $1.7 billion in Q3 2024 and a floor of $739.5 million in Q3 2022.
  • Median Accumulated Expenses over the past 5 years was $889.2 million (2023), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Accumulated Expenses: soared 70.44% in 2024 and later dropped 20.13% in 2025.
  • Edwards Lifesciences' Accumulated Expenses stood at $802.3 million in 2021, then dropped by 0.91% to $795.0 million in 2022, then increased by 7.72% to $856.4 million in 2023, then soared by 49.74% to $1.3 billion in 2024, then increased by 21.78% to $1.6 billion in 2025.
  • The last three reported values for Accumulated Expenses were $1.6 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.